AI assistant
Evotec SE — Board/Management Information 2012
Oct 4, 2012
151_rns_2012-10-04_9497cb3e-ff4e-43f3-83da-fa3f4d271823.html
Board/Management Information
Open in viewerOpens in your device viewer
News Details
Corporate | 4 October 2012 07:24
Evotec AG: Corporate Update
Evotec AG / Key word(s): Miscellaneous
04.10.2012 / 07:24
Hamburg, Germany - 04 October 2012: Evotec AG (Frankfurt Stock Exchange:
EVT, TecDAX) today announced that Dr Werner Lanthaler, CEO of Evotec, will
temporarily stand down from his role within the company due to health
reasons.
Dr Lanthaler informed the Supervisory Board of his situation. The
Supervisory Board has approved his leave of absence and whishes Dr
Lanthaler an early recovery. Following a decision of the Supervisory Board
after consulting Dr Lanthaler, the Management Board of Dr Cord Dohrmann
(CSO) and Colin Bond (CFO) under the direction of Dr Mario Polywka, the
Chief Operating Officer, will lead the company in the absence of Dr
Lanthaler.
Dr Werner Lanthaler will reassume the role of CEO as soon as he has
recovered.
FORWARD LOOKING STATEMENTS - Information set forth in this press release
contains forward-looking statements, which involve a number of risks and
uncertainties. The forward-looking statements contained herein represent
the judgement of Evotec as of the date of this report. Such forward-looking
statements are neither promises nor guarantees, but are subject to a
variety of risks and uncertainties, many of which are beyond our control,
and which could cause actual results to differ materially from those
contemplated in these forward-looking statements. We expressly disclaim any
obligation or undertaking to release publicly any updates or revisions to
any such statements to reflect any change in our expectations or any change
in events, conditions or circumstances on which any such statement is
based.
Contact Evotec AG:
Gabriele Hansen, Head of Corporate Communications, Phone:
+49.(0)40.56081-255, [email protected]
End of Corporate News
04.10.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: Evotec AG
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Phone: +49 (0)40 560 81-0
Fax: +49 (0)40 560 81-222
E-mail: [email protected]
Internet: www.evotec.com
ISIN: DE0005664809
WKN: 566480
Indices: TecDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,
München, Stuttgart
End of News DGAP News-Service
187553 04.10.2012